The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ELCC 2019 | Implementation of low-dose CT lung cancer screening in France
Olivier Leleu
• 3 Jul 2019
Olivier Leleu, MD, of Abbeville Hospital Center, Abbeville, France, discusses the effectiveness and feasibility of implementing low-dose computed tomography (CT) for lung cancer screening in France following the baseline results of DEP KP80 (NCT03853967). This interview took place at the European Lung Cancer Congress (ELCC) 2019, held in Geneva, Switzerland.
